BOSTANEX

BOSTANEX

202207-0267 • 792 Views • Box of 03 blisters x 10 film-coated tablets.
COMPOSITION

Each film-coated tablet contains:

Active ingredient:

Desloratadine 5 mg

Excipients: β-cyclodextrin, sorbitol, sucrose, sodium benzoate, anhydrous citric acid, sodium citrate, sunset yellow, sweet flavor liquid, potassium sorbate, disodium edetate, purified water.

Desloratadine is indicated for the relief of symptoms associated with allergic rhinitis and urticaria.

ADMINISTRATION AND DOSAGE

Dosage

Adults

1 ampoule once daily.

Children

Children 12 years old and over: 1 ampoule once daily.

Children under 12 years old: This product is not recommended for children under 12 years of age.

Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of patient's disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance.

In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more than 4 weeks), continued treatment may be proposed to the patients during the allergen exposure periods.

Administration

BOSTANEX is administered orally. The dose can be taken with or without food.

CONTRAINDICATIONS

Hypersensitivity to the desloratadine, to any of the excipients or to loratadine.

WARNINGS AND PRECAUTIONS

In the case of severe renal insufficiency, desloratadine should be used with caution.

This medicinal product contains sorbitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine.

This medicine contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

PREGNANCY AND LACTATION

Pregnancy 

A large amount of data on pregnant women (more than 1,000 pregnancy outcomes) indicate no malformative nor foeto/neonatal toxicity of desloratadine. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of desloratadine during pregnancy.

Lactation

The effect of desloratadine on newborns/infants is unknown. A decision must be made whether to discontinue breast-feeding or to abstain from desloratadine therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.

SHELF-LIFE

24 months from the manufacturing date. Do not use after the expiry date.

 

 

Box of 03 blisters x 10 film-coated tablets.
Your comment

Similar products

BOSFEXO
Box of 03 blisters x 10 film-coated tablets.
Contact Us
CETIRIZIN BOSTON
Box of 10 blisters x 10 film-coated tablets.
Contact Us
19001910
Confirm information
Please confirm that you are a pharmacist, doctor, medical specialist,... and want to learn about the product. The information described here is only to help readers better understand the product, not for advertising or treatment purposes.